Synthetic Biology is the engineering of biology:
the deliberate (re)design and construction of novel
biological and biologically based parts, devices and systems to perform new functions for useful purposes,
that draws on principles elucidated from biology and engineering.

more information →


ERASynBio aims at promoting the development of synthetic biology by structuring and coordinating national efforts and investment, with the final goal of creating a sound European research community in the field avoiding national fragmentation from the very start.

more information →

ERASynBio Initiative

ERASynBio is an initiative of international funding agencies working together to promote the robust development of Synthetic Biology and to structure and coordinate national efforts and funding programs. The network was created in 2012 and funded as an ERA-Net by the European Commission under FP7 until 2014. From 2015 onwards, ERASynBio will operate as a self-sustainable initiative (i.e. without the financial support of the EC), with most ERA-Net partners continuing their collaboration in the next years.

Along with the 2 joint calls, several supporting measures were initiated by ERASynBio in order to support the development of high quality Synthetic Biology research. One major effort was the development of a Strategic Vision accompanied by a series of targeted recommendations designed to empower national and international funding organizations, policy bodies and other stakeholders.

It is the aim of the ERASynBio initiative to further support joint activities that focus on transnational coordination, capacity building, sharing resources and facilities, and - last but not least - joint calls for proposals in the field of synthetic biology.


Dr. Marion Karrasch-Bott
Phone: +49 2461 61 6245

Current news

New report on synthetic biology and intellectual property rights (IPR) published


A report from the IP (Intellectual property) Expert Meeting at the Danish Agency for Science, Technology & Innovation has been published in the Biotechnical Journal (Biotechnol. J. 2015, 10, 236–241): "Synthetic biology and intellectual property rights: Six recommendations"

On 26th November 2013, the Danish Agency for Science, Technology and Innovation organized an expert meeting on “Synthetic Biology & Intellectual Property Rights” in Copenhagen sponsored by the European Research Area Network in Synthetic Biology (ERASynBio). The meeting brought together ten experts from different countries with a variety of professional backgrounds to discuss emerging challenges and opportunities at the interface of synthetic biology and intellectual property rights. The aim of this article is to provide a summary of the major issues and recommendations discussed during the meeting.


You can find an overview of all news articles here.





CAS Conference Synthetic Biology II

Biocenter, LMU Munich, Martinsried

The second CAS Conference on Synthetic Biology will take place in Munich. It is one of the largest conferences in this field in Europe.
Top European scientists as well as excellent scientists from US are invited. The conference is planned as a platform to exchange and discuss cutting-⁠edge results on Synthetic Biology. The topics will cover all aspects ranging from mirror biology, orthogonal biosystems, metabolic and genome engineering technologies as well as translational aspects of Synthetic Biology.
One of the motivations of this conference is to highlight the current status of the European SynBio activities. This is reflected by the invitations of PI's from all the funded consortia of the first ERAsynbio call. In addition, we would like to link the kick-off for the second call to this meeting as well. Moreover, we will have a special ERASynBio section in the poster session, in which all consortia of both calls are invited to present their project on a poster.